BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10235433)

  • 1. APC resistance and other haemostatic variables during pregnancy and puerperium.
    Kjellberg U; Andersson NE; Rosén S; Tengborn L; Hellgren M
    Thromb Haemost; 1999 Apr; 81(4):527-31. PubMed ID: 10235433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostasis during normal pregnancy and puerperium.
    Hellgren M
    Semin Thromb Hemost; 2003 Apr; 29(2):125-30. PubMed ID: 12709915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemostatic reference intervals in pregnancy.
    Szecsi PB; Jørgensen M; Klajnbard A; Andersen MR; Colov NP; Stender S
    Thromb Haemost; 2010 Apr; 103(4):718-27. PubMed ID: 20174768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostatic changes and acquired activated protein C resistance in normal pregnancy.
    Mahieu B; Jacobs N; Mahieu S; Naelaerts K; Vertessen F; Weyler J; Jacquemyn Y; Van der Planken M
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):685-8. PubMed ID: 17890957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemostatic changes in pregnancy.
    Brenner B
    Thromb Res; 2004; 114(5-6):409-14. PubMed ID: 15507271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of smoking as a risk factor for activated protein C resistance during pregnancy.
    Kafkas S; Kalkan U; Bolaman Z; Sanci M; Yüksel H; Odabaşi AR
    Gynecol Obstet Invest; 2007; 64(2):89-94. PubMed ID: 17314487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia.
    Tchaikovski SN; Thomassen MC; Costa SD; Peeters LL; Rosing J
    Thromb Haemost; 2011 Nov; 106(5):914-21. PubMed ID: 21979881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy.
    Choi JW; Pai SH
    Ann Hematol; 2002 Nov; 81(11):611-5. PubMed ID: 12454697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haemocoagulative modifications correlated with pregnancy].
    Borrelli AL; De Lucia D; Bernacchi M; Napolitano M; Di Domenico A; Felicetti M; Ferrara C; Meo D; Raffio R; Rivetti A; Sessa M; Tagliaferri A; Torella M
    Minerva Ginecol; 2006 Aug; 58(4):315-22. PubMed ID: 16957675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective evaluation of hemostatic system activation and thrombin potential in healthy pregnant women with and without factor V Leiden.
    Eichinger S; Weltermann A; Philipp K; Hafner E; Kaider A; Kittl EM; Brenner B; Mannhalter C; Lechner K; Kyrle PA
    Thromb Haemost; 1999 Oct; 82(4):1232-6. PubMed ID: 10544904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of highly purified urinary FSH and recombinant FSH on haemostasis: an open-label, randomized, controlled trial.
    Ricci G; Cerneca F; Simeone R; Pozzobon C; Guarnieri S; Sartore A; Pregazzi R; Guaschino S
    Hum Reprod; 2004 Apr; 19(4):838-48. PubMed ID: 15016779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calibrated automated thrombin generation in normal uncomplicated pregnancy.
    Rosenkranz A; Hiden M; Leschnik B; Weiss EC; Schlembach D; Lang U; Gallistl S; Muntean W
    Thromb Haemost; 2008 Feb; 99(2):331-7. PubMed ID: 18278182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Glasgow Outcome, APCR and Lipid (GOAL) Pregnancy Study: significance of pregnancy associated activated protein C resistance.
    Clark P; Sattar N; Walker ID; Greer IA
    Thromb Haemost; 2001 Jan; 85(1):30-5. PubMed ID: 11204583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated protein C resistance (FV:Q506) and pregnancy.
    Lindqvist PG; Svensson PJ; Marsaál K; Grennert L; Luterkort M; Dahlbäck B
    Thromb Haemost; 1999 Apr; 81(4):532-7. PubMed ID: 10235434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
    Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
    Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors of thromboembolism associated with pregnancy and the puerperium. Role of inherited and acquired thrombophilia].
    Ducloy-Bouthors AS; Trillot N
    Ann Med Interne (Paris); 2003; 154(5-6):295-300. PubMed ID: 15027582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic changes in the puerperium '6 weeks postpartum' (HIP Study) - implication for maternal thromboembolism.
    Saha P; Stott D; Atalla R
    BJOG; 2009 Nov; 116(12):1602-12. PubMed ID: 19681851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemostatic factors in women with history of preeclampsia.
    Portelinha A; Cerdeira AS; Belo L; Braga J; Tejera E; Pinto A; Pinto F; Areias MJ; Patrício B; Rebelo I
    Thromb Res; 2009 May; 124(1):52-6. PubMed ID: 19049844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.